CD204/MSR1 Proteins, Antibodies, cDNA Clones, ELISA Kits Research Reagents

All CD204/MSR1 reagents are produced in house and quality controlled, including 10 CD204/MSR1 Antibody, 1 CD204/MSR1 ELISA, 28 CD204/MSR1 Gene, 4 CD204/MSR1 Lysate, 4 CD204/MSR1 Protein, 3 CD204/MSR1 qPCR. All CD204/MSR1 reagents are ready to use.

CD204/MSR1 Protein (4)

    CD204/MSR1 Antibody (10)

      CD204/MSR1 ELISA 试剂盒(即用型)& ELISA 抗体对套装(非即用型)(1)

      CD204/MSR1 cDNA Clone (28)

      NM_138715.2

      克隆载体 cDNA 产品

      In lentiviral vector

      L04274.1

      克隆载体 cDNA 产品

      In lentiviral vector

      NM_001191939.1

      克隆载体 cDNA 产品

      In lentiviral vector

      CD204/MSR1 Lysate (4)

        CD204/MSR1 分子背景

        Macrophage scavenger receptor types I and II, also known as Macrophage acetylated LDL receptor I and II, Scavenger receptor class A member 1, CD24, MSR1 and SCARA1, is a single-pass type II membrane protein which contains onecollagen-like domain and oneSRCR domain. Macrophages are distributed in all peripheral tissues and play a critical role in the first line of the innate immune defenses against bacterial infection by phagocytosis of bacterial pathogens through the macrophage scavenger receptor 1 (MSR1). MSR1 / SCARA1 is one of the membrane glycoproteins implicated in the pathologic deposition of cholesterol in arterial walls during atherogenesis. Two types of receptor subunits exist. These receptors mediate the endocytosis of a diverse group of macromolecules, including modified low density lipoproteins (LDL). MSR1 / SCARA1 is also involved in chronic inflammation which is a risk factor for prostate cancer. MSR1 1 gene was identified as a candidate susceptibility gene for hereditary prostate cancer and as a risk factor for sporadic prostate cancer.

        CD204/MSR1 参考文献

        • Wang L. et al., 2003, Nat Genet. 35 (2): 128-9.
        • Chen Y.C. et al., 2008, Cancer Epidemiol Biomarkers Prev. 17 (4): 1001-3.
        • Shirato K. et al., 2009, Pflugers Arch. 459 (1): 93-103.
        • Sun J. et al., 2006, Prostate. 66 (7): 728-37.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.